![Candesartan Cilexetil N1-Trityl Analog ; N1-Trityl Candesartan Cilexetil ; 2-Ethoxy-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy) carbonyl]oxy]ethyl ester; [Candesartan Cilexetil Impurity H]](https://drjcrbio.com/wp-content/uploads/170791-09-0.jpg)
Candesartan Cilexetil N1-Trityl Analog ; N1-Trityl Candesartan Cilexetil ; 2-Ethoxy-1-[[2′-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy) carbonyl]oxy]ethyl ester; [Candesartan Cilexetil Impurity H]
Candesartan, Candesartan Cilexetil N1-Trityl Analog
Description
| Code: JCCAN-08 |
| CAS:170791-09-0 |
| Chemical Formula: C52H48N6O6 |
| Molecular Weight: 852.97 |
| Category: Reference Standards/API Drug Metabolites/EP Impurities/USP Impurities |
| Literature: |
| Application: Candesartan Cilexetil N1-Trityl Analog ; N1-Trityl Candesartan Cilexetil ; 2-Ethoxy-1-[[2′-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy) carbonyl]oxy]ethyl ester; [Candesartan Cilexetil Impurity H] | as reference Impurity standard. |
